Colorcon, a provider of film coatings, excipients, controlled release formulations, and controlled atmosphere packaging for the healthcare industry, has entered an exclusive partnership with LOTTE Fine Chemical, a provider of specialty chemicals, under which Colorcon will be the exclusive representative for the following LOTTE products:
 
AnyCoat-C Hypromellose polymers with applications in solution / suspension, controlled release, and immediate release drug formulations
AnyCoat-P Hypromellose Phthalate polymers for enteric coating, protecting a drug from gastric acid enabling it to be safely delivered into the intestines.
 
“Colorcon is proud to announce our partnership with LOTTE Fine Chemical as we continue to support the formulation development needs of our customers around the world,” stated Kurt Fegely, Vice President of Excipient Technologies for Colorcon. “This partnership combines an impressive product portfolio for immediate, delayed, and controlled release with a global network of technical innovation and service that will accelerate formulation development, helping our customers compete in an increasingly competitive market.”
 
Kim Yong-seok, CEO of LOTTE Fine Chemical, added: “This agreement is significant in that it represents a long-term collaboration in the pharmaceutical cellulose ether market between recognized market leaders. Through this relationship with Colorcon, an organization with proven expertise and leadership in the pharmaceutical industry, we will be able to deliver the most optimized value to our global customers.”
 
The companies’ combined offering positions them to bring enhanced value to their customers and is a demonstration of their commitment to the global pharmaceutical and nutraceutical industries. The partnership will begin on November 1, 2024.